產品描述: | WP1066 is an inhibitor of JAK2 and STAT3, and also shows effect on STAT5 and ERK1/2, without affecting JAK1 and JAK3. |
靶點: |
JAK2;STAT3;Apoptosis;?JAK;?STAT |
體內研究: |
WP1066 (30 mg/kg, o.g.) exerts an additive effect to CTX inhibition of the p-STAT3 pathway within the tumor microenvironment |
參考文獻: |
1. Verstovsek S, et al. WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res, 2008, (3), 788-796. 2. Hatiboglu MA, et al. The tumor microenvironment expression of p-STAT3 influences the efficacy of WP1066 in murine melanoma models. Int J Cancer, 2012, 131(1), 8-17 3. Ferrajoli A, et al. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res, 2007, 67(23), 11291-11299. |
溶解性: |
DMSO : ≥ 44 mg/mL (123.52 mM) Ethanol : 16.67 mg/mL (46.80 mM; Need ultrasonic) |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.807 ml |
14.036 ml |
28.073 ml |
5 mM |
0.561 ml |
2.807 ml |
5.615 ml |
10 mM |
0.281 ml |
1.404 ml |
2.807 ml |
50 mM |
0.056 ml |
0.281 ml |
0.561 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |